JP Stock MarketDetailed Quotes

3401 Teijin

Watchlist
  • 1305.0
  • -0.5-0.04%
20min DelayNot Open Jan 9 15:30 JST
258.33BMarket Cap23.73P/E (Static)

Teijin Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Teijin Q3 2025 Estimates Date

Currency：JPYFeb 6, 2025

Estimate YoY
Revenue
251.60B
-0.59%
Analyst Rating
Hold

Dec 3, 2024

Teijin Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 253.250B--
Feb 6, 20252025/Q3-- / 251.600B--
Nov 7, 20242025/Q2252.162B / 251.250B--
Aug 6, 20242025/Q1255.341B / 254.750B--
May 13, 20242024/Q4273.174B / 264.250B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 253.250B--
Feb 6, 20252025/Q3-- / 251.600B--
Nov 7, 20242025/Q2252.162B / 251.250B--
Aug 6, 20242025/Q1255.341B / 254.750B--
May 13, 20242024/Q4273.174B / 264.250B--

Unlock Free Earnings Estimates

Teijin Earnings Reports

  • Teijin: Confirmation letter

    Nov 12, 2024 20:04 ET

  • Teijin: Interim report - 159th period (2024/04/01 - 2025/03/31)

    Nov 12, 2024 20:03 ET

  • Teijin: Extraordinary Report

    Nov 7, 2024 02:11 ET

  • Teijin: Financial results for the 2nd quarter of fiscal year 2024 and earnings forecast explanatory materials

    Nov 7, 2024 01:30 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Inclusive
    7078
    815 +29.78%
    Renascience
    4889
    382 +26.49%
    Chordia Therapeutics
    190A
    391 +25.72%
    Kufu Company Holdings
    4376
    245 +16.67%
    Cube
    7112
    570 +16.33%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 3, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      80.00%

    • Underperform

      0.00%

    • Sell

      20.00%

    Price Target

    No Data